278 related articles for article (PubMed ID: 17679801)
1. Preventing cardiovascular disease and diabetes: a call to action from the ADA and AHA.
Wyne KL
J Cardiometab Syndr; 2006; 1(3):220-1. PubMed ID: 17679801
[No Abstract] [Full Text] [Related]
2. The metabolic syndrome revisited: "cardiometabolic risk" emerges as common ground between differing views of the ADA and AHA.
Stern N; Izkhakov Y
J Cardiometab Syndr; 2006; 1(5):362-3. PubMed ID: 17679794
[No Abstract] [Full Text] [Related]
3. Dyslipidemia in the metabolic syndrome in children.
Gidding SS
J Cardiometab Syndr; 2006; 1(4):282-5. PubMed ID: 17679808
[TBL] [Abstract][Full Text] [Related]
4. Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association.
Buse JB; Ginsberg HN; Bakris GL; Clark NG; Costa F; Eckel R; Fonseca V; Gerstein HC; Grundy S; Nesto RW; Pignone MP; Plutzky J; Porte D; Redberg R; Stitzel KF; Stone NJ; ;
Circulation; 2007 Jan; 115(1):114-26. PubMed ID: 17192512
[TBL] [Abstract][Full Text] [Related]
5. Preventing cardiovascular disease and diabetes: a call to action from the American Diabetes Association and the American Heart Association.
Eckel RH; Kahn R; Robertson RM; Rizza RA
Diabetes Care; 2006 Jul; 29(7):1697-9. PubMed ID: 16801605
[No Abstract] [Full Text] [Related]
6. Preventing cardiovascular disease and diabetes: a call to action from the American Diabetes Association and the American Heart Association.
Eckel RH; Kahn R; Robertson RM; Rizza RA
Circulation; 2006 Jun; 113(25):2943-6. PubMed ID: 16801475
[No Abstract] [Full Text] [Related]
7. Updated Cardiovascular Prevention Guideline of the Brazilian Society of Cardiology - 2019.
Précoma DB; Oliveira GMM; Simão AF; Dutra OP; Coelho OR; Izar MCO; Póvoa RMDS; Giuliano ICB; Alencar Filho AC; Machado CA; Scherr C; Fonseca FAH; Santos Filho RDD; Carvalho T; Avezum Á; Esporcatte R; Nascimento BR; Brasil DP; Soares GP; Villela PB; Ferreira RM; Martins WA; Sposito AC; Halpern B; Saraiva JFK; Carvalho LSF; Tambascia MA; Coelho-Filho OR; Bertolami A; Correa Filho H; Xavier HT; Faria-Neto JR; Bertolami MC; Giraldez VZR; Brandão AA; Feitosa ADM; Amodeo C; Souza DDSM; Barbosa ECD; Malachias MVB; Souza WKSB; Costa FAAD; Rivera IR; Pellanda LC; Silva MAMD; Achutti AC; Langowiski AR; Lantieri CJB; Scholz JR; Ismael SMC; Ayoub JCA; Scala LCN; Neves MF; Jardim PCBV; Fuchs SCPC; Jardim TSV; Moriguchi EH; Schneider JC; Assad MHV; Kaiser SE; Lottenberg AM; Magnoni CD; Miname MH; Lara RS; Herdy AH; Araújo CGS; Milani M; Silva MMFD; Stein R; Lucchese FA; Nobre F; Griz HB; Magalhães LBNC; Borba MHE; Pontes MRN; Mourilhe-Rocha R
Arq Bras Cardiol; 2019 Nov; 113(4):787-891. PubMed ID: 31691761
[No Abstract] [Full Text] [Related]
8. Treating the cardiometabolic syndrome: an opportunity to provide comprehensive cardiovascular risk reduction.
Basile J; Houston M; Ferrario CM
J Cardiometab Syndr; 2006; 1(5):358-61. PubMed ID: 17679795
[No Abstract] [Full Text] [Related]
9. Application of recent definitions of the metabolic syndrome to survey data from the National Cholesterol Education Program Evaluation Project Utilizing Novel E-Technology (NEPTUNE II).
Deedwania PC; Maki KC; Dicklin MR; Stone NJ; Ballantyne CM; Davidson MH
J Cardiometab Syndr; 2006; 1(5):295-300. PubMed ID: 17679790
[TBL] [Abstract][Full Text] [Related]
10. Triple threat: diabetes, hypertension, and heart disease.
Woods A; Moshang J
Nurs Manage; 2005 Nov; 36(11):27-33; quiz 33-4. PubMed ID: 16272897
[TBL] [Abstract][Full Text] [Related]
11. Abdominal obesity and cardiovascular disease risk: the emerging role of the adipocyte.
Lee YH; Pratley RE
J Cardiopulm Rehabil Prev; 2007; 27(1):2-10. PubMed ID: 17474638
[No Abstract] [Full Text] [Related]
12. [Nutrition and metabolic syndrome].
Matía Martín P; Lecumberri Pascual E; Calle Pascual AL
Rev Esp Salud Publica; 2007; 81(5):489-505. PubMed ID: 18274353
[TBL] [Abstract][Full Text] [Related]
13. Association of age and sex with cardiovascular risk factors and insulin sensitivity in overweight children and adolescents.
Koenigsberg J; Boyd GS; Gidding SS; Hassink SG; Falkner B
J Cardiometab Syndr; 2006; 1(4):253-8. PubMed ID: 17679813
[TBL] [Abstract][Full Text] [Related]
14. Metabolic syndrome: cardiovascular risk assessment and management.
Wong ND
Am J Cardiovasc Drugs; 2007; 7(4):259-72. PubMed ID: 17696567
[TBL] [Abstract][Full Text] [Related]
15. Management of cardiovascular risk in patients with type 2 diabetes mellitus as a component of the cardiometabolic syndrome.
Ferdinand KC
J Cardiometab Syndr; 2006; 1(2):133-40. PubMed ID: 17679832
[TBL] [Abstract][Full Text] [Related]
16. The relationships between cardiovascular disease and diabetes: focus on pathogenesis.
Kovacic JC; Castellano JM; Farkouh ME; Fuster V
Endocrinol Metab Clin North Am; 2014 Mar; 43(1):41-57. PubMed ID: 24582091
[TBL] [Abstract][Full Text] [Related]
17. Preventing CVD in Adults with Type 2 Diabetes Mellitus: An Update from the AHA and ADA.
Hauk L
Am Fam Physician; 2016 Feb; 93(3):232-3. PubMed ID: 26926617
[No Abstract] [Full Text] [Related]
18. Drug treatment of metabolic syndrome.
Altabas V
Curr Clin Pharmacol; 2013 Aug; 8(3):224-31. PubMed ID: 22950955
[TBL] [Abstract][Full Text] [Related]
19. Metabolic syndrome: controversial but useful.
Stolar M
Cleve Clin J Med; 2007 Mar; 74(3):199-202, 205-8. PubMed ID: 17375800
[TBL] [Abstract][Full Text] [Related]
20. Check up America: reduce cardiometabolic risk. Clinical tools of the American Diabetes Association.
Armani AM
Crit Pathw Cardiol; 2007 Jun; 6(2):60-3. PubMed ID: 17667866
[No Abstract] [Full Text] [Related]
[Next] [New Search]
